• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.5MM X 17MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.5MM X 17MM - PMAS; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number FDS45017
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Visual Disturbances (2140)
Date of Event 12/20/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that in the clinical trial the subject flow diverter was implanted in a patient for aneurysm in left internal carotid artery-ophthalmic (c6 segment) on (b)(6) 2021.Post procedure the patient had a previous visit on (b)(6) 2021 for transient vision changes involving both the eyes, which resolved on its own on the same day.Ct and mri diagnostic tests performed came back normal as per site reporting.At the visit patient was prescribed norco 5-325 mg for fibromyalgia pain.On (b)(6) 2022, the imr (designated cec member) has assessed the transient vision changes in the patient had possible relation to the subject flow diverter, procedure and the dual antiplatelet therapy.No other information is available.
 
Additional Manufacturer Narrative
The device is not available to the manufacturer as the subject device was implanted inside the patient's vasculature.
 
Event or Problem Description
It was reported that in the clinical trial the subject flow diverter was implanted in a patient for aneurysm in left internal carotid artery-ophthalmic (c6 segment) on (b)(6) 2021.Post procedure the patient had a previous visit on (b)(6) 2021 for transient vision changes involving both the eyes, which resolved on its own on the same day.Ct and mri diagnostic tests performed came back normal as per site reporting.At the visit patient was prescribed norco 5-325 mg for fibromyalgia pain.On (b)(6) 2022, the imr (designated cec member) has assessed the transient vision changes in the patient had possible relation to the subject flow diverter, procedure and the dual antiplatelet therapy.No other information is available.
 
Additional Manufacturer Narrative
D4 expiration date - added.H4 manufacturing date ¿ added.Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.It was reported that transient vision changes, affected both eyes (indicated as bilateral).No abnormality on mir.However need results of ophthalmoscopy, fundoscopy fully evaluate.Based upon medical review, the harm observed in this complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted within the dfu, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to the as reported 'patient neurological deficit' for this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURPASS EVOLVE 4.5MM X 17MM - PMAS
Common Device Name
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key14315679
Report Number3008881809-2022-00205
Device Sequence Number5000678
Product Code OUT
UDI-Device Identifier07613327386639
UDI-Public07613327386639
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P170024/S003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2023
Device Model NumberFDS45017
Device Catalogue NumberFDS45017
Device Lot Number22622266
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/11/2022
Supplement Date Received by Manufacturer07/18/2022
Initial Report FDA Received Date05/07/2022
Supplement Report FDA Received Date08/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/01/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age58 YR
Patient SexFemale
Patient Weight85 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-